keyword
https://read.qxmd.com/read/38631490/neutrophil-derived-nanovesicles-deliver-il-37-to-mitigate-renal-ischemia-reperfusion-injury-via-endothelial-cell-targeting
#21
JOURNAL ARTICLE
Wenjie Ma, Di Wu, Chengcheng Long, Jingyu Liu, Luwei Xu, Liuhua Zhou, Quanliang Dou, Yuzheng Ge, Changcheng Zhou, Ruipeng Jia
Renal ischemia-reperfusion injury (IRI) is one of the most important causes of acute kidney injury (AKI). Interleukin (IL)-37 has been suggested as a novel anti-inflammatory factor for the treatment of IRI, but its application is still limited by its low stability and delivery efficiency. In this study, we reported a novel engineered method to efficiently and easily prepare neutrophil membrane-derived vesicles (N-MVs), which could be utilized as a promising vehicle to deliver IL-37 and avoid the potential side effects of neutrophil-derived natural extracellular vesicles...
April 15, 2024: Journal of Controlled Release
https://read.qxmd.com/read/38630690/transcutaneous-carbon-dioxide-suppresses-skeletal-muscle-atrophy-in-a-mouse-model-of-oral-squamous-cell-carcinoma
#22
JOURNAL ARTICLE
Aki Sasaki, Daisuke Takeda, Hotaka Kawai, Yoshiaki Tadokoro, Aki Murakami, Nanae Yatagai, Satomi Arimoto, Hitoshi Nagatsuka, Masaya Akashi, Takumi Hasegawa
Cancer cachexia causes skeletal muscle atrophy, impacting the treatment and prognosis of patients with advanced cancer, but no treatment has yet been established to control cancer cachexia. We demonstrated that transcutaneous application of carbon dioxide (CO2) could improve local blood flow and reduce skeletal muscle atrophy in a fracture model. However, the effects of transcutaneous application of CO2 in cancer-bearing conditions are not yet known. In this study, we calculated fat-free body mass (FFM), defined as the skeletal muscle mass, and evaluated the expression of muscle atrophy markers and uncoupling protein markers as well as the cross-sectional area (CSA) to investigate whether transcutaneous application of CO2 to skeletal muscle could suppress skeletal muscle atrophy in cancer-bearing mice...
2024: PloS One
https://read.qxmd.com/read/38627724/impact-of-grade-on-workup-of-rectal-neuroendocrine-tumors-a-retrospective-cohort-study-grade-impact-on-workup-of-rectal-nets
#23
JOURNAL ARTICLE
Akie Watanabe, Sabrina Rai, Lily Yip, Carl J Brown, Jonathan M Loree, Heather C Stuart
BACKGROUND: Rectal neuroendocrine tumors (RNETs) are often discovered on screening colonoscopy. Indications for staging and definitive resection are inconsistent in current guidelines. We evaluated the role of grade in guiding staging and procedural decision-making. METHODS: Patients with biopsy confirmed RNETs between 2004 and 2015 were reviewed. Baseline characteristics, staging investigations (biochemical and imaging), and endoscopic/surgical treatment were recorded...
April 16, 2024: World Journal of Surgical Oncology
https://read.qxmd.com/read/38627212/mechanism-of-dexmedetomidine-protection-against-cisplatin-induced-acute-kidney-injury-in-rats
#24
JOURNAL ARTICLE
Zeng-Lu Zheng, Jun-Wei Ma, Yi Luo, Gui-Jin Liang, Shi-Jie Lei, Ke-Jin Yan, Hai-Bing Meng, Xiu-Juan Liu
OBJECTIVE: This study explored the molecular mechanisms by which dexmedetomidine (Dex) alleviates cisplatin (CP)-induced acute kidney injury (AKI) in rats. METHODS: CP-induced AKI models were established, and Dex was intraperitoneally injected at different concentrations into rats in the model groups. Subsequently, rats were assigned to the control, CP, CP + Dex 10 μg/kg, and CP + Dex 25 μg/kg groups. After weighing the kidneys of the rats, the kidney arterial resistive index was calculated, and CP-induced AKI was evaluated...
December 2024: Renal Failure
https://read.qxmd.com/read/38621759/hemoadsorption-consensus-report-of-the-30th-acute-disease-quality-initiative-workgroup
#25
JOURNAL ARTICLE
Ghada Ankawi, Sean M Bagshaw, Rinaldo Bellomo, Ian Baldwin, Rajit Basu, Gabriella Bottari, Vincenzo Cantaluppi, William Clark, Silvia De Rosa, Lui G Forni, Dana Fuhrman, Stuart Goldstein, Hernando Gomez, Faeq Husain-Syed, Michael Joannidis, Kianoush Kashani, Anna Lorenzin, Ravindra Mehta, Patrick T Murray, Ragi Murugan, Marlies Ostermann, Neesh Pannu, Vedran Premuzic, John Prowle, Thiago Reis, Thomas Rimmelé, Claudio Ronco, Mitch Rosner, Antoine Schneider, Emily See, Danielle Soranno, Gianluca Villa, Adam Whaley-Connell, Alexander Zarbock
Adsorption-based extracorporeal therapies have been subject to technical developments and clinical application for close to five decades. More recently, new technological developments in membrane and sorbent manipulation have made it possible to deliver more biocompatible extracorporeal adsorption therapies to patients with a variety of conditions. There are several key rationales based on physicochemical principles and clinical considerations that justify the application and investigation of such therapies as evidenced by multiple ex-vivo, experimental, and clinical observations...
April 15, 2024: Nephrology, Dialysis, Transplantation
https://read.qxmd.com/read/38616933/risk-factors-of-acute-kidney-injury-during-hospitalization-in-acute-ischaemic-stroke-patients-undergoing-mechanical-thrombectomy
#26
JOURNAL ARTICLE
Paweł Wrona, Katarzyna Sawczyńska, Dominik Wróbel, Kaja Zdrojewska, Mateusz Giełczyński, Paweł Mizera, Paweł Brzegowy, Tadeusz Popiela, Agnieszka Słowik, Marcin Krzanowski
INTRODUCTION: Acute kidney injury (AKI) seems to worsen the prognosis of acute ischaemic stroke (AIS) patients treated with mechanical thrombectomy (MT). At the same time, the procedure of MT increases AKI risk by iodinated contrast use. Identification of factors predisposing to AKI after MT is important for recognizing vulnerable patients and successful prevention. AIM: To identify factors associated with the occurrence of AKI during hospitalization in MT-treated AIS patients...
March 2024: Postępy W Kardiologii Interwencyjnej, Advances in Interventional Cardiology
https://read.qxmd.com/read/38616273/sodium-bicarbonate-and-intubation-in-severe-diabetic-ketoacidosis-are-we-too-quick-to-dismiss-them
#27
JOURNAL ARTICLE
Manudi Vidanapathirana
Management of diabetic ketoacidosis (DKA) has internationally established guidelines. However, management of severe, refractory DKA with multiple contributors to acidosis, and management of DKA in patients with altered mentation, remain ambiguous. Use of sodium bicarbonate and intubation in DKA are unpopular treatment practices, but warrant consideration in these unique clinical scenarios. This paper describes a 61-year-old Sri Lankan female who presented with severe DKA, seizures and altered level of consciousness...
April 15, 2024: Clinical Diabetes and Endocrinology
https://read.qxmd.com/read/38615919/butyrate-promotes-kidney-resilience-through-a-coordinated-kidney-protective-response-in-tubular-cells
#28
JOURNAL ARTICLE
Chiara Favero, Aranzazu Pintor-Chocano, Ana Sanz, Alberto Ortiz, Maria D Sanchez-Niño
Acute kidney injury (AKI) is common in hospitalized patients and increases short-term and long-term mortality. Treatment options for AKI are limited. Gut microbiota products such as the short-chain fatty acid butyrate have anti-inflammatory actions that may protect tissues, including the kidney, from injury. However, the molecular mechanisms of tissue protection by butyrate are poorly understood. Treatment with oral butyrate for two weeks prior to folic acid-induced AKI and during AKI improved kidney function and decreased tubular injury and kidney inflammation while stopping butyrate before AKI was not protective...
April 12, 2024: Biochemical Pharmacology
https://read.qxmd.com/read/38614389/the-key-role-of-altered-tubule-cell-lipid-metabolism-in-kidney-disease-development
#29
REVIEW
Lauren E Lee, Tomohito Doke, Dhanunjay Mukhi, Katalin Susztak
Kidney epithelial cells have very high energy requirements, which are largely met by fatty acid oxidation. Complex changes in lipid metabolism are observed in patients with kidney disease. Defects in fatty acid oxidation and increased lipid uptake, especially in the context of hyperlipidemia and proteinuria, contribute to this excess lipid build-up and exacerbate kidney disease development. Recent studies have also highlighted the role of increased de novo lipogenesis in kidney fibrosis. The defect in fatty acid oxidation will cause energy starvation...
April 11, 2024: Kidney International
https://read.qxmd.com/read/38613209/mortality-rates-in-patients-undergoing-urgent-versus-elective-transcatheter-aortic-valve-replacement-a-meta-analysis
#30
JOURNAL ARTICLE
Anastasios Apostolos, Nikolaos Ktenopoulos, Dimitrios-David Chlorogiannis, Odysseas Katsaros, Konstantinos Konstantinou, Maria Drakopoulou, Sotirios Tsalamandris, Antonios Karanasos, Andreas Synetos, Georgios Latsios, Constantina Aggeli, Vasileios Panoulas, Costas Tsioufis, Konstantinos Toutouzas
Patients with severe aortic stenosis (AoS) often present with acute heart failure and compensation, frequently leading to cardiogenic shock. Transcatheter Aortic Valve Replacement (TAVR) has been recently performed as a bailout treatment in such patients. The aim of our meta-analysis is to compare urgent TAVR with elective procedures. We systematically screened three databases searching for studies comparing urgent vs elective TAVR. Primary endpoint is the 30-days mortality. Secondary endpoints included in-hospital mortality, device success, periprocedural vascular complications, 30-days stroke, 30-days acute kidney injury (AKI), permanent pacemaker implantation (PPM), moderate or severe paravalvular leakage, and 30-days bleeding...
April 13, 2024: Angiology
https://read.qxmd.com/read/38612416/galectin-3-and-autophagy-in-renal-acute-tubular-necrosis
#31
JOURNAL ARTICLE
Suhail Al-Salam, Govindan S Jagadeesh, Manjusha Sudhadevi, Javed Yasin
Acute kidney injury (AKI) is a public health burden with increasing morbidity and mortality rates and health care costs. Acute tubular necrosis (ATN) is the most common cause of AKI. Cisplatin (CIS) is a platinum-based chemotherapeutic agent used in the treatment of a wide variety of malignancies such as lung, breast, ovary, testis, bladder, cervix, and head and neck cancers. Autophagy plays an important role in AKI. Galectin-3 (Gal-3) is significantly increased in renal tubules in AKI; however, its role in autophagy is not well understood...
March 22, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38610806/contrast-induced-acute-kidney-injury-in-patients-with-heart-failure-on-sodium-glucose-cotransporter-2-inhibitors-undergoing-radiocontrast-agent-invasive-procedures-a-propensity-matched-analysis
#32
JOURNAL ARTICLE
Giulia Nardi, Enrico Marchi, Marco Allinovi, Gianmarco Lugli, Lucrezia Biagiotti, Francesca Maria Di Muro, Renato Valenti, Iacopo Muraca, Benedetta Tomberli, Niccolò Ciardetti, Brunetto Alterini, Francesco Meucci, Carlo Di Mario, Alessio Mattesini
(1) Background : This single-center retrospective study aimed to evaluate whether sodium-glucose cotransporter-2 inhibitors (SGLT2-i) therapy may have a nephroprotective effect to prevent contrast-induced acute kidney injury (CI-AKI) in patients with heart failure (HF) undergoing iodinated contrast medium (ICM) invasive procedures. (2) Methods : The population was stratified into SGLT2-i users and SGLT2-i non-users according to the chronic treatment with gliflozins. The primary endpoint was CI-AKI incidence during hospitalization...
April 1, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38610593/immunohistochemical-evaluation-of-renal-biopsy-with-anti-pd1-and-p53-to-solve-the-dilemma-between-platinum-and-pembrolizumab-induced-aki-case-report-and-review
#33
Nicoletta Mancianti, Sergio Antonio Tripodi, Alessandra Pascucci, Marta Calatroni, Edoardo La Porta, Andrea Guarnieri, Guido Garosi
Introduction : The combination therapy of platinum and pembrolizumab looks like a promising treatment in advanced non-small-cell lung cancer. However, both platinum-based chemotherapy and pembrolizumab can lead to AKI. AKI can occur due to acute tubular necrosis or interstitial nephritis. It is essential to identify the drug responsible for renal damage. For this purpose, we used new immunohistochemistry markers (p53 and anti-PD1 analysis). Case Description : A 77-year-old female patient with advanced non-small-cell lung cancer received the PD-1 inhibitor pembrolizumab and platinum-based chemotherapy carboplatin...
March 22, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38608193/effectiveness-of-intravenous-methylprednisolone-pulse-in-patients-with-severe-microscopic-polyangiitis-and-granulomatosis-with-polyangiitis
#34
JOURNAL ARTICLE
Satoshi Omura, Takashi Kida, Hisashi Noma, Hironori Inoue, Hideaki Sofue, Aki Sakashita, Masatoshi Kadoya, Daiki Nakagomi, Yoshiyuki Abe, Naoho Takizawa, Atsushi Nomura, Yuji Kukida, Naoya Kondo, Yasuhiko Yamano, Takuya Yanagida, Koji Endo, Shintaro Hirata, Kiyoshi Matsui, Tohru Takeuchi, Kunihiro Ichinose, Masaru Kato, Ryo Yanai, Yusuke Matsuo, Yasuhiro Shimojima, Ryo Nishioka, Ryota Okazaki, Tomoaki Takata, Takafumi Ito, Mayuko Moriyama, Ayuko Takatani, Yoshia Miyawaki, Toshiko Ito-Ihara, Nobuyuki Yajima, Takashi Kawaguchi, Aiko Hirano, Kazuki Fujioka, Wataru Fujii, Takahiro Seno, Makoto Wada, Masataka Kohno, Yutaka Kawahito
OBJECTIVES: To evaluate the effectiveness and safety of two different intravenous methylprednisolone (IVMP) pulse doses in patients with severe microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA). METHODS: We emulated a target trial using observational data from the nationwide registry in Japan. Patients with severe glomerulonephritis or diffuse alveolar haemorrhage were selected and pseudo-randomised into three groups using propensity score-based overlap weighting as follows: non-IVMP, IVMP 0...
April 12, 2024: Rheumatology
https://read.qxmd.com/read/38607518/pioglitazone-ameliorates-ischemia-reperfusion-induced-acute-kidney-injury-via-oxidative-stress-attenuation-and-nlrp3-inflammasome
#35
JOURNAL ARTICLE
Zhenfeng Ye, Jing Zhang, Zhou Xu, Zhangwang Li, Gaomin Huang, Bin Tong, Panpan Xia, Yunfeng Shen, Honglin Hu, Peng Yu, Xiaoqing Xi
Acute kidney injury (AKI) induced by renal ischemia/reperfusion injury (IRI) is a severe clinical condition. ROS accumulation, antioxidant pathways deficiency, and inflammation are involved in IRI. Pioglitazone (Pio) exerts anti-inflammatory and antioxidant effects. The aim of this study was to explore the protective effects of pioglitazone against IRI-induced AKI. Pathogen-free Sprague-Dawley (SD) rats were arbitrarily divided into four groups: Sham operation group Control (CON) group, CON + Pio group, I/R + Saline group, and I/R + Pio group...
April 12, 2024: Human Cell
https://read.qxmd.com/read/38606975/effect-modification-of-dosing-strategy-auc-or-trough-on-aki-associated-with-vancomycin-in-combination-with-piperacillin-tazobactam-or-cefepime-and-meropenem
#36
JOURNAL ARTICLE
Breanne Mefford, Katie L Wallace, J Chris Donaldson, Brittany D Bissell Turpin, Parijat Sen, Aric D Schadler, Lucas J Liu, Melissa L Thompson Bastin
Piperacillin-tazobactam (TZP), cefepime (FEP), or meropenem (MEM) and vancomycin (VAN) are commonly used in combination for sepsis. Studies have shown an increased risk of acute kidney injury (AKI) with TZP and VAN compared to FEP or MEM. VAN guidelines recommend area under the curve (AUC) monitoring over trough (Tr) to minimize the risk of AKI. We investigated the association of AKI and MAKE-30 with the two VAN monitoring strategies when used in combination with TZP or FEP/MEM. Adult patients between 2015 and 2019 with VAN > 72 hours were included...
April 12, 2024: Antimicrobial Agents and Chemotherapy
https://read.qxmd.com/read/38605938/tobramycin-systemic-absorption-in-lung-transplant-recipients-treated-with-inhaled-tobramycin-a-cohort-study
#37
JOURNAL ARTICLE
Abiu Sempere, Ibai Los-Arcos, Judith Sacanell, Cristina Berastegui, David Campany-Herrero, Jaume Vima, María Teresa Martín-Gómez, Leire Sánchez, Daniel Martínez-González, Carles Bravo, Oscar Len, Joan Gavaldà
Inhaled tobramycin treatment has been associated with nephrotoxicity in some case reports, but limited data are available about serum levels and its possible systemic absorption in lung transplant recipients (LTR). We conducted a single-center, observational and retrospective study of all adult (>18 years old) LTR treated with inhaled tobramycin for at least 3 days between June 2019 and February 2022. Trough serum levels were collected and >2 μg/mL was considered a high drug level...
2024: Transplant International
https://read.qxmd.com/read/38604071/melanin-concentrating-hormone-receptor-1-is-discarded-by-exosomes-after-internalization
#38
JOURNAL ARTICLE
Ryohei Yamada, Momoka Michimae, Akie Hamamoto, Hiroshi Takemori
Melanin-concentrating hormone (MCH) receptor 1 (MCHR1), a G protein-coupled receptor, is poised for interaction with its ligands on the plasma membrane. Analyses of MCHR1 knockout mice suggest that this receptor could be a therapeutic target for the treatment of appetite disorders, glucose metabolism, psychiatric disorders, and inflammation. Binding of MCH to MCHR1 initiates calcium signaling, which is subsequently attenuated through receptor internalization. However, the ultimate destiny of the receptor post-internalization remains unexplored...
April 7, 2024: Biochemical and Biophysical Research Communications
https://read.qxmd.com/read/38600585/allogeneic-bone-marrow-mesenchymal-stem-cell-derived-exosomes-alleviate-human-hypoxic-aki-on-a-chip-within-a-tight-treatment-window
#39
JOURNAL ARTICLE
Sefa Burak Çam, Eda Çiftci, Nazlıhan Gürbüz, Bülent Altun, Petek Korkusuz
BACKGROUND: Acute hypoxic proximal tubule (PT) injury and subsequent maladaptive repair present high mortality and increased risk of acute kidney injury (AKI) - chronic kidney disease (CKD) transition. Human bone marrow mesenchymal stem cell-derived exosomes (hBMMSC-Exos) as potential cell therapeutics can be translated into clinics if drawbacks on safety and efficacy are clarified. Here, we determined the real-time effective dose and treatment window of allogeneic hBMMSC-Exos, evaluated their performance on the structural and functional integrity of 3D microfluidic acute hypoxic PT injury platform...
April 10, 2024: Stem Cell Research & Therapy
https://read.qxmd.com/read/38594773/quillaja-saponin-mitigates-methotrexate-provoked-renal-injury-insight-into-nrf-2-keap-1-pathway-modulation-with-suppression-of-oxidative-stress-and-inflammation
#40
JOURNAL ARTICLE
Mustafa Ahmed Abdel-Reheim, Merhan E Ali, Ahmed Gaafar A Gaafar, Ahmed Amine Ashour
BACKGROUND: Methotrexate (MTX) is an antineoplastic/immunosuppressive drug, whose clinical use is impeded owing to its serious adverse effects; one of which is acute kidney injury (AKI). Most of MTX complications emerged from the provoked pro-oxidant-, pro-inflammatory- and pro-apoptotic effects. Quillaja saponaria bark saponin (QBS) is a bioactive triterpene that has been traditionally used as an antitussive, anti-inflammatory supplement, and to boost the immune system due to its potent antioxidant- and anti-inflammatory activities...
April 9, 2024: Journal of Pharmaceutical Health Care and Sciences
keyword
keyword
71040
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.